Brief: Idorsia Reacquires The World-Wide Rights To Aprocitentan

Idorsia

06/09/2023 06:08

Sept 6 (Reuters) - Idorsia Ltd  IDIA.S :
    * IDORSIA REACQUIRES THE WORLD-WIDE RIGHTS TO APROCITENTAN
    * IDORSIA IS COMMITTED TO PAY UP TO 306 MILLION SWISS
FRANCS,
SUBJECT TO MARKETING APPLICATION APPROVAL BY US FDA AND EUROPE'S
EMA.
    * IDORSIA WILL REACQUIRE DEVELOPMENT AND COMMERCIALIZATION
RIGHTS
FOR APROCITENTAN FROM JANSSEN
    * AGREEMENT ALSO ELIMINATES REVENUE-SHARING AGREEMENT IN
RESPECT
OF PONESIMOD

Source text for Eikon:  ID:nGNE7wYg8s 
Further company coverage:  IDIA.S 

 ((Reuters.Briefs@thomsonreuters.com;))